Psychedelics have a bad reputation because of the movies, the media, and the government. The scare tactics worked to an extent, but the drug classification laid out in the scheduling of drugs is what turned a harmless personal experience with a mind-altering substance into the potential for decades inside a prison cell.
However, the tide is starting to turn as the medical industry has begun to take an interest in the power of these mysterious substances for fixing PTSD and depression. With a “breakthrough therapy” designation by the FDA in 2019, psilocybin has taken the next step toward gaining approval and being allowed to be considered to treat mental issues that millions of people struggle with each day.